Skip to main content
. 2017 Feb 27;28(7):2201–2210. doi: 10.1681/ASN.2016111162

Table 5.

Risk prediction models with and without inclusion of serum uromodulin

Model All-Cause Mortality Cardiovascular Mortality
AUC (95% CI) Harrell C Statistic AUC (95% CI) Harrell C Statistic
No history of CVD
 ESC heart score 0.721 (0.69 to 0.75) 0.70 0.724 (0.69 to 0.76) 0.71
 ESC heart score and uromodulin 0.729 (0.70 to 0.76) 0.70 0.744 (0.71 to 0.78)a 0.73
 PCE 0.732 (0.70 to 0.76) 0.71 0.733 (0.70 to 0.77) 0.72
 PCE and uromodulin 0.736 (0.70 to 0.79) 0.71 0.750 (0.71 to 0.79)b 0.74
Previous CVD
 Marshner score 0.727 (0.70 to 0.76) 0.69 0.696 (0.66 to 0.73) 0.69
 Marshner and uromodulin 0.735 (0.70 to 0.77) 0.70 0.704 (0.67 to 0.74) 0.70
 VILCAD risk score 0.744 (0.71 to 0.77) 0.71 0.740 (0.71 to 0.77) 0.74
 VILCAD risk score and uromodulin 0.748 (0.72 to 0.78) 0.72 0.741 (0.71 to 0.78) 0.74

Model including uromodulin versus base model. AUC, area under the curve; CVD, cardiovascular disease; VILCAD, Vienna and Ludwigshafen Coronary Artery Disease.

a

P<0.05.

b

P<0.10.